Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Reaction mass ofDisodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN1}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-) andDisodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN2}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-)
EC number: 944-038-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics, other
- Type of information:
- other: Assessment based on physicochemical properties and toxicological data available as recommended by ECHA REACH guidance
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
- toxicokinetics
- Principles of method if other than guideline:
- Assessment based on physicochemical proeprties and toxicological data available as recommended by ECHA REACH guidance.
- GLP compliance:
- no
- Conclusions:
- Acid Black 107 would be absorbed primarily in gastrointestinal tract, while some absorption via dermal and inhalation exposure can be expected. Systemic distribution would most likely occur via the serum, while metabolism would be limited and excretion expected to occur via the urine and feces.
- Executive summary:
Acid Black107 would be absorbed primarily in gastrointestinal tract, while some absorption via dermal and inhalation exposure can be expected. Systemic distribution would most likely occur via the serum, while metabolism would be limited and excretion expected to occur via the urine and feces.
Reference
Absorption
Oral/gastrointestinal absorption:
Based on the molecular weight of 884.6 g/mol for Acid Black 107, it can be assumed to have moderate oral absorption. With the high water solubility of 55 g/L, Acid Black 107 may readily dissolve into the gastrointestinal fluids and be absorbed via passive diffusion.
In the acute oral toxicity studies with Acid Black 107, higher doses (>1000 mg/kg bw) caused dyspnoea, ataxia, ventricumbency, muscular hypotonia, inhibition of the response to pain (pinching), diarrhea, hyperreflexia, hypoventilation and reduction in spontaneous motility. 2 out 5 females died at 8000 mg/kg bw.
In the combined repeated dose toxicity study with reproductive and developmental screening with the structurally similar substance Acid blue 317, oral administration of the test substance lead tochanges that included blue staining of various parts of the body, blue bedding, blue/dark faeces. The macroscopic examination performed on animals which received Acid Blue 317 at 300 and 1000 mg/kg bw/day, revealed abnormal (blue) colouration of skeletal muscle, sciatic nerves, mammary tissue, axillary lymph nodes, brain, eyes, and the majority of the tissues in the abdominal and thoracic cavities, with abnormal colouration of the contents of the gastro‑intestinal (GI) tract. Blue colouration in animals receiving 100 mg/kg bw/day, was generally limited to the mesenteric lymph nodes, contents of the GI tract and staining of the tails in occasional males. At the high dose level, external blue staining of the offspring was apparent in-life and confirmed at necropsy.
These findings were indicative of absorption taking place from the gastrointestinal tract. Hence, on the basis of hydrophilic nature and the findings of the toxicological studies as discussed above, Acid Black 107 is expected to be absorbed by the gastrointestinal tract when administered orally.
Dermal absorption:
Based on the molecular weight of 884.6g/mol for Acid Black 107, poor dermal absorption is expected. With high solubility in water (55 g/L) and low partition coefficient (0.357), dermal uptake is expected to be low as Acid Black 107 can be considered to be hydrophilic in nature to cross the lipid rich environment of the stratum corneum.The surface tension of 50.6 mN/m for Acid Black 107 also suggests a low dermal uptake from skin surfaces.
Acid Black 107 is neither corrosive nor irritating to the skin or eyes. It was not sensitising to the skin of guinea pigs. Hence, the experimental data also suggests a low dermal uptake. However, the findings from the acute oral toxicity studies with Acid Black 107 as well as combined repeated dose oral toxicity study with reproductive and developmental screening with Acid Blue 317, indicates the potential for absorption following ingestion and it is therefore possible that the substance will also be absorbed if it is exposed dermally. Nonetheless, absorption will be limited and only substantial at higher dosage and the test substance will be quickly excreted owing to the high water solubility.
Respiratory absorption:
Acid Black 107 exists as a solid powder and expected to have low volatility based on high melting point of >350°C, and hence may not be available in inhalable forms. Further, the high water solubility (55 g/L), indicates that the dust will be trapped in the mucus if it happens to enter the respiratory tract. However, the findings from the acute oral toxicity studies with Acid Black 107 as well as combined repeated dose oral toxicity study with reproductive and developmental screening with Acid Blue 317, indicate the potential for absorption following ingestion and it is therefore possible that the substance will also be absorbed if it is inhaled. Nonetheless, absorption will be limited and only substantial at higher dosage and the test substance will be quickly excreted owing to the high water solubility.
Distribution
Systemic distribution due to the high water solubility would most likely occur via the serum. Owing to the high molecular size and hydrophilic nature of the substance (low n-octanol/water partition coefficient and high water solubility), access of Acid Black 107 to the central nervous system (CNS) or testes is likely to be restricted by the blood-brain and blood-testes barriers, whileaccumulation in body fat is unlikely to occur. However,in thecombined repeated dose oral toxicity study with reproductive and developmental screening with Acid Blue 317, at 1000 mg/kg bw/day, external blue staining of the offspring was apparent in-life and confirmed at necropsy. Hence, it is evident that ACID BLUE 317 was able to cross the placental barrier. Based on this, Acid Black 107 can also be expected to cross placental barrier.
Metabolism
In the genetic toxicity studies including a bacterial reverse mutation assay, a mammalian cell gene mutation assay and a micronucleus assay with Acid Black 107, and available toxicity studies, there was no evidence to indicate Acid Black 107 or metabolite influenced hepatic metabolism. Further the high water solubility of Acid Black 107 suggests that metabolism would be limited and not required to facilitate renal excretion.
Excretion
Route of excretion for Acid Black 107 has not been investigated. However, in the combined repeated dose oral toxicity study with reproductive and developmental screening with Acid Blue 317, test substance administration at high doses lead to blue/dark faeces. Hence, excretion through faeces may also a play a role in the excretion of the substance. However, owing to the hydrophilic nature of the substance, it will be expected to be predominantly excreted via urine.
Description of key information
Acid Black 107 would be absorbed primarily in gastrointestinal tract, while some absorption via dermal and inhalation exposure can be expected. Systemic distribution would most likely occur via the serum, while metabolism would be limited and excretion expected to occur via the urine and feces.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.